Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Sections
    • Collections
  • Podcasts
  • Author Info
    • Overview for authors
    • Publication fees
    • Forms
    • Editorial policies
    • Submit a manuscript
    • Open access
  • Careers
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CJS
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • JAMC
    • JPN
CJS

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Sections
    • Collections
  • Podcasts
  • Author Info
    • Overview for authors
    • Publication fees
    • Forms
    • Editorial policies
    • Submit a manuscript
    • Open access
  • Careers
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow CJS on Twitter
Review
Open Access

Reduction of opioid use after orthopedic surgery: a scoping review

Jessica Gormley, Kyle Gouveia, Seaher Sakha, Veronica Stewart, Ushwin Emmanuel, Michael Shehata, Daniel Tushinski, Harsha Shanthanna and Kim Madden
CAN J SURG October 20, 2022 65 (5) E695-E715; DOI: https://doi.org/10.1503/cjs.023620
Jessica Gormley
From the Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ont. (Gormley, Gouveia, Stewart, Shehata); the Faculty of Science, McMaster University, Hamilton, Ont. (Sakha, Emmanuel); the Department of Surgery, McMaster University, Hamilton, Ont. (Tushinski, Madden); the Hamilton Health Sciences – Juravinski Hospital, Hamilton, Ont. (Tushinski); the Department of Anesthesia, McMaster University, Hamilton, Ont. (Shanthanna); and St. Joseph’s Healthcare Hamilton, Hamilton, Ont. (Shanthanna, Madden)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyle Gouveia
From the Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ont. (Gormley, Gouveia, Stewart, Shehata); the Faculty of Science, McMaster University, Hamilton, Ont. (Sakha, Emmanuel); the Department of Surgery, McMaster University, Hamilton, Ont. (Tushinski, Madden); the Hamilton Health Sciences – Juravinski Hospital, Hamilton, Ont. (Tushinski); the Department of Anesthesia, McMaster University, Hamilton, Ont. (Shanthanna); and St. Joseph’s Healthcare Hamilton, Hamilton, Ont. (Shanthanna, Madden)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seaher Sakha
From the Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ont. (Gormley, Gouveia, Stewart, Shehata); the Faculty of Science, McMaster University, Hamilton, Ont. (Sakha, Emmanuel); the Department of Surgery, McMaster University, Hamilton, Ont. (Tushinski, Madden); the Hamilton Health Sciences – Juravinski Hospital, Hamilton, Ont. (Tushinski); the Department of Anesthesia, McMaster University, Hamilton, Ont. (Shanthanna); and St. Joseph’s Healthcare Hamilton, Hamilton, Ont. (Shanthanna, Madden)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronica Stewart
From the Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ont. (Gormley, Gouveia, Stewart, Shehata); the Faculty of Science, McMaster University, Hamilton, Ont. (Sakha, Emmanuel); the Department of Surgery, McMaster University, Hamilton, Ont. (Tushinski, Madden); the Hamilton Health Sciences – Juravinski Hospital, Hamilton, Ont. (Tushinski); the Department of Anesthesia, McMaster University, Hamilton, Ont. (Shanthanna); and St. Joseph’s Healthcare Hamilton, Hamilton, Ont. (Shanthanna, Madden)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ushwin Emmanuel
From the Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ont. (Gormley, Gouveia, Stewart, Shehata); the Faculty of Science, McMaster University, Hamilton, Ont. (Sakha, Emmanuel); the Department of Surgery, McMaster University, Hamilton, Ont. (Tushinski, Madden); the Hamilton Health Sciences – Juravinski Hospital, Hamilton, Ont. (Tushinski); the Department of Anesthesia, McMaster University, Hamilton, Ont. (Shanthanna); and St. Joseph’s Healthcare Hamilton, Hamilton, Ont. (Shanthanna, Madden)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Shehata
From the Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ont. (Gormley, Gouveia, Stewart, Shehata); the Faculty of Science, McMaster University, Hamilton, Ont. (Sakha, Emmanuel); the Department of Surgery, McMaster University, Hamilton, Ont. (Tushinski, Madden); the Hamilton Health Sciences – Juravinski Hospital, Hamilton, Ont. (Tushinski); the Department of Anesthesia, McMaster University, Hamilton, Ont. (Shanthanna); and St. Joseph’s Healthcare Hamilton, Hamilton, Ont. (Shanthanna, Madden)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Tushinski
From the Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ont. (Gormley, Gouveia, Stewart, Shehata); the Faculty of Science, McMaster University, Hamilton, Ont. (Sakha, Emmanuel); the Department of Surgery, McMaster University, Hamilton, Ont. (Tushinski, Madden); the Hamilton Health Sciences – Juravinski Hospital, Hamilton, Ont. (Tushinski); the Department of Anesthesia, McMaster University, Hamilton, Ont. (Shanthanna); and St. Joseph’s Healthcare Hamilton, Hamilton, Ont. (Shanthanna, Madden)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harsha Shanthanna
From the Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ont. (Gormley, Gouveia, Stewart, Shehata); the Faculty of Science, McMaster University, Hamilton, Ont. (Sakha, Emmanuel); the Department of Surgery, McMaster University, Hamilton, Ont. (Tushinski, Madden); the Hamilton Health Sciences – Juravinski Hospital, Hamilton, Ont. (Tushinski); the Department of Anesthesia, McMaster University, Hamilton, Ont. (Shanthanna); and St. Joseph’s Healthcare Hamilton, Hamilton, Ont. (Shanthanna, Madden)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim Madden
From the Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ont. (Gormley, Gouveia, Stewart, Shehata); the Faculty of Science, McMaster University, Hamilton, Ont. (Sakha, Emmanuel); the Department of Surgery, McMaster University, Hamilton, Ont. (Tushinski, Madden); the Hamilton Health Sciences – Juravinski Hospital, Hamilton, Ont. (Tushinski); the Department of Anesthesia, McMaster University, Hamilton, Ont. (Shanthanna); and St. Joseph’s Healthcare Hamilton, Hamilton, Ont. (Shanthanna, Madden)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Abstract

Background: The opioid epidemic is one of the biggest public health crises of our time, and overprescribing of opioids after surgery has the potential to lead to long-term use. The purpose of this review was to identify and summarize the available evidence on interventions aimed at reducing opioid use after orthopedic surgery.

Methods: We searched CENTRAL, Embase and Medline from inception until August 2019 for studies comparing interventions aimed at reducing opioid use after orthopedic surgery to a control group. We recorded demographic data and data on intervention success, and recorded or calculated percent opioid reduction compared to control.

Results: We included 141 studies (20 963 patients) in the review, of which 113 (80.1%) were randomized controlled trials (RCTs), 6 (4.3%) were prospective cohort studies, 16 (11.4%) were retrospective cohort studies, 5 (3.6%) were case reports, and 1 (0.7%) was a case series. The majority of studies (95 [67.4%]) had a follow-up duration of 2 days or less. Interventions included the use of local anesthetics and/or nerve blocks (42 studies [29.8%]), nonsteroidal anti-inflammatory drugs (31 [22.0%]), neuropathic pain medications (9 [6.4%]) and multimodal analgesic combinations (25 [17.7%]. In 127 studies (90.1%), a significant decrease in postoperative opioid consumption compared to the control intervention was reported; the median opioid reduction in these studies was 39.7% (range 5%–100%). Despite these reductions in opioid use, the effect on pain scores and on incidence of adverse effects was inconsistent.

Conclusion: There is a large body of evidence from randomized trials showing the promise of a variety of interventions for reducing opioid use after orthopedic surgery. Rigorously designed RCTs are needed to determine the ideal interventions or combination of interventions for reducing opioid use, for the good of patients, medicine and society.

The conflict and tension between the intended good and unintended harms of opioids have been recognized within the medical context since the early 1900s.1 It is helpful to separate the harms broadly into 2 categories: short-term adverse effects, which are adverse drug effects experienced by the person using the drug, and long-term harms, which could be to the individual or to society (diversion). The immediate harms are considered under the term opioid-related adverse drug effects and they commonly include nausea/vomiting, sedation, itching, postoperative ileus and respiratory depression.2 Secondarily, they can lead to increased length of stay, opioid dependence, death and rising costs.3,4

The long-term harms of opioids are specifically responsible for the ongoing opioid epidemic in North America, as well as in other parts of the world.5 Over the past 20 years, opioid use disorder and opioid-related mortality have increased rapidly.6 In 2013, drug overdose surpassed motor vehicle crashes to become the leading cause of preventable death in the United States, with more than 42 000 opioid overdose deaths in 2016 alone.7,8 The number of opioid-related deaths has continued to rise, with an increase in deaths in Canada in 2017 of 30% from the previous year.7 These trends are matched by a marked increase in patient opioid prescriptions. In Canada, the defined daily dose per million population per day of opioids increased threefold between 2001–2003 and 2012–2014, from 10 209 to 30 540.7,8 This is second only to the US.7

In light of the current opioid epidemic, increased attention has been given to target areas to reduce opioid use and manage acute pain alternatively in the postoperative period. Owing to the substantial amount of pain after many orthopedic procedures, opioids have traditionally been used postoperatively in this field. There are many risks to consider when prescribing, which makes the issues at hand incredibly complex. Prescribing opioids peri- and postoperatively can trigger long-term use in people independent of opioid tolerance or previous use.9 A retrospective cohort study from Ontario showed increased risk of long-term opioid use after receiving a prescription for a short-stay surgery in 44% of 400 000 patients.9 In opioid-naive patients, a new opioid prescription after discharge from hospital increased the odds of long-term use 1 year later by 4.9 times (95% confidence interval 3.22–7.45).10 Two of the 3 surgical interventions that were associated with highest long-term opioid use were total knee arthroplasty (TKA) and total hip arthroplasty (THA).11 Other risks to consider include the possibility that the legal supply will be diverted to those with substance use disorder or people seeking illicit drugs.12,13 Studies repeatedly show that more than 50% of prescribed opioids go unused, and the majority are never disposed of safely.14

Managing pain is a key component of patient care. For opioid-reduction programs to be successful, they must recognize the challenges around pain, particularly in older patients and those with chronic pain, including the potential for persisting pain after surgery and, hence, the necessity of providing alternative analgesic modalities that depend less on opioids. Programs that aim to reduce opioid use substantially should not only focus on the physiologic management of pain, but also consider education initiatives on opioid use and assess for patients at high risk. To reduce dependency on opioids, pain should be managed with a multimodal analgesia regimen. This includes the use of pharmacologic modalities such as peripheral nerve blocks (PNBs) or local anesthetic infiltration (LAI), acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) in all patients, and the use of gabapentinoids and cannabinoids in suitable patients. Nonpharmacologic modalities that are considered as adjuncts include acupuncture, electrotherapy and transcutaneous electrical nerve stimulation.15–17 Evidence suggests that many of these modalities are underused.18,19

The goals of this scoping review were to 1) identify the current literature and level of evidence on reduction of opioid use after orthopedic surgery; 2) describe the interventions used; 3) summarize the results, noting the amount of opioid reduction and other postoperative outcomes; and 4) synthesize the results to highlight patterns seen with different interventions.

Methods

Protocol and registration

We conducted a scoping review of published literature on strategies to reduce opioid use in orthopedic surgery. The purpose of a scoping review is to map the current literature on a broad topic to identify gaps in the literature in order to plan future studies and to identify areas where there is enough information to conduct formal meta-analyses. This scoping review protocol was registered with the PROSPERO international prospective register of systematic reviews (CRD42020153418). The methodology of the review is in accordance with the PRISMA-ScR guidelines for scoping reviews.20

Literature search

We completed a comprehensive search of CENTRAL, Embase and Medline from database inception until August 2019 for studies aiming to eliminate or substantially reduce perioperative opioid use. Terms searched included common orthopedic interventions, analgesic options, alternative therapy options to manage acute pain and any phrases that suggest there has been a reduction in opioid use. We then performed an extensive manual search of reference lists from the included literature to seek any additional relevant studies. Our search strategy for each of the 3 databases is presented in Appendix 1 (available at www.canjsurg.ca/lookup/doi/10.1503/cjs.023620/tab-related-content).

Studies were included if at least 25% of the population were orthopedic surgery patients; they were original reports focused on perioperative and/or acute postoperative pain management (i.e., not chronic pain); the primary objective of the study was to reduce or eliminate perioperative or postoperative opioid use; and full-text articles were available. Studies were excluded if they were animal or preclinical studies, were in a language other than English, focused on cancer pain, focused exclusively on pediatric populations, or were opinion pieces, editorials or synthesis of literature, including reviews.

We managed references using Rayyan QCRI software (Qatar Computing Research Institute). Two reviewers (J.G., V.S.) independently screened titles identified by the literature search first and then all remaining abstracts. Any study that was distinctly irrelevant based on the eligibility criteria was excluded. At both the title and the abstract stage, a study was included if at least 1 of the 2 reviewers chose to include it. Full texts were obtained for all remaining studies when available. Both reviewers screened the remaining references independently. Any initial discrepancies at the full-text stage were resolved by discussion between the reviewers until agreement on inclusion or exclusion of the study in question was reached.

We extracted the data using a collaborative online spreadsheet (Google Sheets). The form included study characteristics (design, date, location, sample size, demographic characteristics and level of evidence), description of the population, intervention, comparator (if applicable) and relevant outcomes at final follow-up. The spreadsheet was piloted by 2 reviewers (J.G., V.S.) before data extraction. Each reviewer’s data were audited by the other reviewer using a random spot-check method.

Data analysis

As this was a scoping review, we presented our analysis and results in a descriptive fashion. We used frequencies and proportions for categoric data, and means and standard deviations, or median and range (depending on data distribution) for continuous data. We grouped studies based on type of orthopedic procedure: arthroplasty procedures (knee and/or hip), arthroscopy operations, spinal procedures and other peripheral limb procedures. We reported the category of opioid-sparing strategy used as pharmacologic or nonpharmacologic, and noted the type of interventions used within these categories as NSAIDs, acetaminophen derivatives, adjunct analgesic medications (gabapentinoids), PNBs, LAI, physical modalities, psychologic modalities and other. We noted the amount of opioid sparing or reduction as per the study reporting, including the dosage and duration of opioid therapy.

Results

The initial literature search yielded 20 309 studies; after removal of duplicates, this number was reduced to 14 121. Systematic screening and assessment of eligibility yielded 141 full-text articles that satisfied the criteria for inclusion (Figure 1).

Fig. 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1

Flow diagram showing study selection

Study quality

Of the 141 studies, 113 (80.1%) were randomized controlled trials (RCTs) (level I evidence), 6 (4.3%) were prospective cohort studies (level II evidence), 16 (11.3%) were retrospective cohort studies (level III evidence), 5 (3.5%) were case reports (level IV evidence), and 1 (0.7%) was a case series (level IV evidence).

Study characteristics

The 141 studies included in this review involved 20 963 patients (Table 1). The number of included patients per study ranged from 1 to 4046 (median 68). In the studies that reported gender, 9585/17 511 patients (54.7%) were female. The overall mean age was 57.8 (range 16–94) years. The length of follow-up ranged from 0.83 to 365 days, with 95 studies (67.4%) having 2 days or less of follow-up, 24 studies (17.0%) having 3–7 days of follow-up, and 12 studies (8.5%) having more than 7 days of follow-up.

View this table:
  • View inline
  • View popup
Table 1

Characteristics of included studies

There were 158 total intervention arms aimed at reducing opioid use, of which 145 (91.8%) were pharmacologic. The most commonly used pharmacologic interventions, either alone or in some combination, were PNB/LAI, acetaminophen, NSAIDs and additional analgesics (most commonly gabapentin). In 25 studies (17.7%), the use of a multimodal regimen (defined as the use of ≥ 2 analgesics) aimed at reducing opioid use was reported. Nonpharmacologic interventions included education (4 studies115,132,155,160), transcutaneous electrical nerve stimulation (3 studies69,112,126), transcranial direct current stimulation (2 studies24,97) and, in 1 study each, auricular acupressure, cryotherapy and millimetre wave therapy.33,48,49

Of the 141 studies, 139 (98.6%) (19 795 patients) included only patients who had orthopedic procedures. The most common procedures performed were lower limb total joint arthroplasty, with 38 studies (7124 patients) involving TKA, 25 studies (2346 patients) involving THA and 7 studies (730 patients) involving both, for a total of 70 studies (49.6%) examining pain control specifically after lower limb arthroplasty. The next most common surgical procedures were spinal surgery (29 studies [20.6%], 5013 patients) and arthroscopic surgery (15 studies [10.6%], 1160 patients). There were 27 studies on other surgical procedures, including fracture fixation.

In 127 studies (90.1%), a significant decrease in postoperative opioid consumption compared to the control intervention was reported; the median opioid reduction in these studies was 39.7% (range 5%–100%).

Procedures

Total knee arthroplasty

Among the 38 TKA studies, PNB/LAI was used in 15 (40%), NSAIDs were used in 5 (13%), a nonpharmacologic intervention was used in 4 (10%), and additional adjuvant analgesics were used in 5 (13%) (Table 1). Multimodal analgesia was used in 9 studies (24%).

A statistically significant reduction in opioid use compared to the control group was reported in 34 studies (90%) (Table 2). Percent opioid reduction ranged from 10% to 100% (median 37.8%). Twenty-three studies (60%) showed at least a 30% reduction in opioid use, and 12 (32%) showed more than a 50% reduction.

View this table:
  • View inline
  • View popup
Table 2

Major outcomes of included studies*

Of the 36 studies in which pain scores were reported, 26 (72%) showed significantly lower scores compared to the control intervention. Postoperative length of stay was reported in 5 studies, with all 5 showing significantly lower values compared to control. Mobilization was reported in 10 studies, of which 8 (80%) showed significant improvement compared to control. Patient satisfaction was reported in 2 studies,29,32 1 of which showed significantly higher satisfaction compared to control. The frequency of adverse events was reported in 17 studies, with 4 (24%) showing the intervention had a significantly positive effect; the remaining 13 studies (76%) showed no difference between the intervention and control groups.

Total hip arthroplasty

Among the 25 THA studies, PNB/LAI was used in 8 (32%), NSAIDs were used in 6 (24%), a nonpharmacologic intervention was used in 1 (4%),69 and additional adjuvant analgesics were used in 5 (21%). Multimodal analgesia was used in 5 studies (21%).

Twenty-four studies (96%) showed a statistically significant reduction in opioid use compared to control. Percent opioid reduction ranged from 15% to 100% (median 40.3%). Eighteen studies (72%) showed at least a 30% reduction in opioid use, and 6 studies (24%) showed more than a 50% reduction.

Pain scores were reported in 20 studies, 13 (65%) of which showed significantly lower scores compared to the control intervention. Postoperative length of stay was reported in 3 studies,77,80,83 all of which showed significantly lower values compared to control. Of the 2 studies in which mobilization was reported,62,80 1 showed significant improvement compared to control.80 Patient satisfaction was reported in 2 studies;59,75 both showed significantly higher satisfaction compared to control. The frequency of adverse events was reported in 16 studies, 6 (38%) of which showed a significantly lower incidence compared to control.

Total knee and total hip arthroplasty

Among the 7 studies in patients underwent THA or TKA, the intervention consisted of PNB/LAI in 1 (14%),87 NSAIDs in 3 (43%),86,88,89 acetaminophen in 1 (14%),90 additional adjuvant analgesics in 1 (14%)85 and multimodal analgesia in 1 (14%).84 Six studies (86%) showed a statistically significant reduction in opioid use compared to control. Percent opioid reduction ranged from 23.4% to 89.3% (median 36.3%). Four studies (57%) showed at least a 30% reduction in opioid use, and 2 studies (29%) showed more than a 50% reduction.

Pain scores were reported in 4 studies, all of which showed a significant decrease. The frequency of adverse events was reported by 4 studies; all 4 indicated that the intervention had no impact on the frequency of adverse events.

Arthroscopy

Among the 15 arthroscopy studies, PNB/LAI was used in 5 (33%), NSAIDs were used in 4 (27%), a nonpharmacologic intervention was used in 2 (13%),126,132 gabapentinoids were used in 3 (20%),120,128,129 and additional adjuvant analgesics were used in 1 (7%).

Fourteen studies (93%) showed a statistically significant reduction in opioid use compared to control. Percent opioid reduction ranged from 14% to 89% (median 40.6%). Nine studies (60%) showed a reduction in opioid use of at least 30%, and 5 studies (33%) showed a reduction of more than 50%.

Pain scores were reported in 11 studies, of which 9 (82%) showed significantly lower scores compared to the control intervention. The 1 study121 in which postoperative length of stay was reported indicated significantly lower values compared to control. Patient satisfaction was reported in 1 study,125 which showed that the intervention had a significantly positive effect. The frequency of adverse events was reported in 7 studies, 1 (14%) of which showed a significantly lower incidence compared to control.

Spinal surgery

Among the 29 spinal surgery studies, the intervention consisted of PNB/LAI in 4 (14%), NSAIDs in 6 (21%), acetaminophen in 2 (7%),99,117 a nonpharmacologic intervention in 3 (10%),97,112,115 gabapentinoids in 3 (10%)94,105,110 and additional adjuvant analgesics in 4 (14%). Multimodal analgesia was used in 7 studies (24%).

A statistically significant reduction in opioid use compared to control was reported in 27 studies (93%). Percent opioid reduction ranged from 8.5% to 100% (median 35.3%). Of the 29 studies, 19 (66%) showed at least a 30% reduction in opioid use, and 9 (31%) showed more than a 50% reduction.

Pain scores were reported in 25 studies, of which 13 (52%) showed significantly lower scores compared to the control intervention. Of the 2 studies in which postoperative length of stay was reported,93,95 1 showed significantly lower values compared to control. Mobilization was reported in 1 study,114 which showed a significant improvement compared to control. Patient satisfaction was reported in 2 studies,98,103 with 1 showing significantly higher satisfaction compared to control.98 The frequency of adverse events was reported in 15 studies, of which 3 (20%) indicated that the intervention had a significant improvement on the incidence of adverse events; the remaining studies showed no difference between the intervention and control groups.

Other orthopedic surgery

Among the 27 studies on other surgical procedures, PNB/LAI was used in 7 (26%), NSAIDs in 7 (26%), acetaminophen in 3 (11%),137,148,159 a nonpharmacologic intervention in 2 (7%)155,160 and additional adjuvant analgesics in 5 (18%). Multimodal analgesia was used in 3 studies (11%).151,154,156

Twenty-four studies (89%) showed a statistically significant opioid reduction compared to control. Percent opioid reduction ranged from 3% to 100% (median 40%). A reduction in opioid use of at least 30% was reported in 20 studies (74%), and a reduction in opioid use of more than 50% was reported in 9 studies (33%).

Pain scores were reported in 20 studies, with 10 (50%) showing significantly lower scores compared to the control intervention. Both studies148,156 in which postoperative length of stay was reported indicated significantly lower values compared to control. The frequency of adverse events was reported in 16 studies, with 3 (19%) showing significantly lower values compared to control; in the remaining studies, no difference was observed between the intervention and control groups.

Discussion

Our review was a comprehensive review of the literature on reduction in opioid use after orthopedic surgery. It was conducted systematically with rigorous methodology, as outlined in the PRISMA extension for scoping reviews.20 Although a majority (81.6%) of the included studies showed a reduction in opioid consumption of at least 25%, the reduction was not associated with a simultaneous positive effect on pain scores or the incidence of adverse events.

A majority (67.4%) of studies included a follow-up duration of 2 days or less, with only 8.5% having a followup duration of more than 7 days. This is a major drawback when one is trying to infer the potential for limiting persistent opioid use after orthopedic surgery.

Even among studies that reported a significant decrease in opioid use, a reduction in opioid-related adverse drug effects was reported or observed inconsistently. This may be a result of the particular type of intervention, as well as its potential to affect pain directly and its relative effect on adverse effects. For example, the use of gabapentin, although associated with decreased opioid use, has been shown to be associated with substantial sedation and risk of adverse effects on its own.162

Opioid sparing is most possible with the use of a multimodal approach rather than a single, nonopioid substitute; however, this approach continues to be underused or applied inconsistently.163–166 In our review, multimodal analgesia was used in less than 25% of studies within each procedure type.

It is also relevant to note that postsurgical pain can be influenced by many patient- and procedure-dependent factors. In addition, studies have shown significant variation in pain-resolution patterns,167–170 and analgesic consumption is dynamic and changes with time.171

An important factor not reported in many studies is the use of preoperative screening based on known risk factors for long-term opioid use after surgery, including male sex, age more than 50 years, prior opioid use, alcohol abuse and mental illness.11,172,173 As well, the use of benzodiazepines or antidepressants preoperatively has been found to be associated with a higher risk of long-term opioid use postoperatively.11,174 Future trials should consider screening protocols to evaluate risk in potential patients.175,176 One step toward this has been preoperative screening and referral to pain specialists for patients with preoperative long-term opioid use.114,177

The context of opioid use in hospital and its effect on long-term opioid use is still unclear. Although studies have shown a reduction in inpatient opioid consumption, especially with implementation of Enhanced Recovery After Surgery pathways,178,179 there is no evidence to suggest that limiting intraoperative administration of opioids influences the risk of long-term opioid use postoperatively.180–182 The most direct contributor to long-term opioid use identified in the literature is inappropriate physician prescribing.11,171,183 An observational study showed that opioids are prescribed postoperatively to 98.3% of patients in North America, compared to 70.2% of patients in Europe, although the mean worst pain scores were higher in North American patients than in patients from Europe (7.4/10 v. 5.4/10).184 Yet although opioid prescribing has been identified as the problem, it seems that very few investigators have incorporated this factor in their interventions. In a scoping review of opioid-free analgesia after major surgery, Fiore and colleagues185 observed that a majority of RCTs compared opioid-free strategies only during the hospital stay, and only 7 targeted postdischarge analgesia.

In view of these challenges, education as a nonpharmacologic tool to reduce opioid consumption and alleviate pain may play an important role. However, in the present review, an educational intervention was used in only 4 studies (2.8%); all showed significant reduction in opioid use, ranging from 22.1% to 54.5%. Notably, these studies involved education in many different forms, whether for prescribers115,160 or patients.132 Bohl and colleagues116 investigated the use of a multimodal analgesia protocol that included preoperative counselling in addition to a variety of different classes of analgesic medications pre-, intra- and postoperatively. Similarly, Ali and colleagues114 used an Enhanced Recovery After Surgery protocol involving preoperative education and screening for long-term opioid use, as well as multimodal perioperative analgesia. Both studies showed significant positive effects on opioid consumption. A recent systematic review of institutional interventions such as education, counselling and prescribing guidelines showed that, on the patient side, educational programs were most effective, and on the provider side, the use of prescribing guidelines was most effective.186 Although there is scant evidence available on these types of interventions, with only 13 studies being included in that systematic review, there is reason to believe that these institutional strategies will be crucial in tackling this complex problem.

Somewhat unexpectedly, the majority (80.1%) of studies that included evidence on reducing opioid consumption after orthopedic surgery in the present review were randomized studies. This not only suggests the importance of this problem in this surgical specialty, but also identifies opportunities for synthesis of available information in the form of appropriate meta-analyses and network meta-analyses to investigate the relative merits and effect size of opioid reduction with individual interventions or combination of interventions.16,187,188

Future trials should also consider methodologic issues in surgical trials looking at opioid reduction. Measuring opioid use, for either relative increase or decrease, in postsurgical trials can be challenging: apart from the weak correlation between pain intensity and opioid use, there may also be issues of sedation accompanying adjuvant analgesics.189,190 Ideally, there should be some integrated measure of pain intensity and analgesic (opioid) demand.191

Limitations

One limitation of this review is the inclusion of all levels of evidence instead of only evidence from RCTs. As well, much of the data gathered were reported simply in terms of whether or not there was improvement, with many studies reporting little quantitative data. However, the purpose of this scoping review was to identify literature and general results, with the goal of directing areas for future research, as well as guiding the development of study protocols incorporating a variety of both pharmacologic and nonpharmacologic interventions. Included studies were relatively small, with a median sample of 68 participants, and relatively short, with a median follow-up duration of 2 days. Last, there was a wide variety of procedures with varying levels of postoperative pain represented in the included studies.

Conclusion

This scoping review showed that there is a large body of evidence, much of it from randomized trials, that shows the promise of both pharmacologic and nonpharmacologic interventions in the goal of reduction of opioid use after orthopedic surgery. However, rigorously designed RCTs incorporating evidence-based pharmacologic and nonpharmacologic interventions in a multimodal regimen are needed to evaluate the goal of reducing opioid use, for the good of patients, medicine and society.

Footnotes

  • Contributors: J. Gormley, D. Tushinski and K. Madden designed the study. K. Gouveia, S. Sakha, V. Stewart, U. Emmanuel and M. Shehata acquired the data, which V. Stewart and H. Shanthanna analyzed. J. Gormley, K. Gouveia, S. Sakha, V. Stewart, U. Emmanuel, M. Shehata and K. Madden wrote the manuscript, which D. Tushinski and H. Shanthanna critically revised. All authors gave final approval of the article to be published.

  • Competing interests: Kim Madden reports research support from the Research Institute of St. Joe’s Hamilton, the Canadian Institutes of Health Research, BioTalent Canada and McMaster University, outside the submitted work. She has participated on a data safety monitoring board at the University of Calgary. She is an associate editor for Clinical Orthopaedics and Related Research and Pilot and Feasibility Studies, and sits on the Equity, Diversity and Inclusion Committee of the Society for Clinical Trials. No other competing interests were declared.

  • Accepted January 7, 2022.

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

References

  1. ↵
    1. Rosenblum A,
    2. Marsch LA,
    3. Joseph H,
    4. et al
    . Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol 2008;16:405–16.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Herzig SJ,
    2. Rothberg MB,
    3. Cheung M,
    4. et al
    . Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals. J Hosp Med 2014;9:73–81.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Kane-Gill SL,
    2. Rubin EC,
    3. Smithburger PL,
    4. et al
    . The cost of opioid-related adverse drug events. J Pain Palliat Care Pharmacother 2014;28:282–93.
    OpenUrlPubMed
  4. ↵
    1. Shafi S,
    2. Collinsworth AW,
    3. Copeland LA,
    4. et al
    . Association of opioid-related adverse drug events with clinical and cost outcomes among surgical patients in a large integrated health care delivery system. JAMA Surg 2018;153:757–63.
    OpenUrl
  5. ↵
    Opioid overdose deaths. Atlanta: Centers for Disease Control and Prevention; 2019. Available: https://www.cdc.gov/drugoverdose/ (accessed 2019 Oct. 24).
  6. ↵
    1. Chen LH,
    2. Hedegaard H,
    3. Warner M
    . Drug-poisoning deaths involving opioid analgesics: United States, 1999–2011. NCHS Data Brief 2014;166:1–8.
    OpenUrlPubMed
  7. ↵
    1. Donroe JH,
    2. Socias ME,
    3. Marshall BDL
    . The deepening opioid crisis in North America: historical context and current solutions. Curr Addict Rep 2018;5:454–63.
    OpenUrl
  8. ↵
    1. Rudd RA,
    2. Aleshire N,
    3. Zibbell JE,
    4. et al
    . Increases in drug and opioid overdose deaths — United States, 2000–2014. MMWR Morb Mortal Wkly Rep 2016;64:1378–82.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Alam A,
    2. Gomes T,
    3. Zheng H,
    4. et al
    . Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med 2012; 172:425–30.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Calcaterra SL,
    2. Yamashita TE,
    3. Min SJ,
    4. et al
    . Opioid prescribing at hospital discharge contributes to chronic opioid use. J Gen Intern Med 2016;31:478–85.
    OpenUrlPubMed
  11. ↵
    1. Sun EC,
    2. Darnall BD,
    3. Baker LC,
    4. et al
    . Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern Med 2016;176:1286–93.
    OpenUrlPubMed
  12. ↵
    1. Walker MJ,
    2. Webster LR
    . Risk factors for drug diversion in a pain clinic patient population. J Opioid Manag 2012;8:351–62.
    OpenUrl
  13. ↵
    1. Theisen K,
    2. Jacobs B,
    3. Macleod L,
    4. et al
    . The United States opioid epidemic: a review of the surgeon’s contribution to it and health policy initiatives. BJU Int 2018;122:754–9.
    OpenUrl
  14. ↵
    1. Callinan CE,
    2. Neuman MD,
    3. Lacy KE,
    4. et al
    . The initiation of chronic opioids: a survey of chronic pain patients. J Pain 2017;18: 360–5.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Hah JM,
    2. Bateman BT,
    3. Ratliff J,
    4. et al
    . Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic. Anesth Analg 2017;125:1733–40.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Tedesco D,
    2. Gori D,
    3. Desai KR,
    4. et al
    . Drug-free interventions to reduce pain or opioid consumption after total knee arthroplasty: a systematic review and meta-analysis. JAMA Surg 2017;152:e172872.
    OpenUrl
  17. ↵
    1. Hickernell TR,
    2. Lakra A,
    3. Berg A,
    4. et al
    . Should cannabinoids be added to multimodal pain regimens after total hip and knee arthroplasty? J Arthroplasty 2018;33:3637–41.
    OpenUrlPubMed
  18. ↵
    1. Busse JW,
    2. Craigie S,
    3. Juurlink DN,
    4. et al
    . Guideline for opioid therapy and chronic noncancer pain. CMAJ 2017;189:E659–66.
    OpenUrlFREE Full Text
  19. ↵
    1. Madden K,
    2. Bhandari M
    . Cochrane in CORR®: interventions for the reduction of prescribed opioid use in chronic non-cancer pain. Clin Orthop Relat Res 2018;476:932–3.
    OpenUrl
  20. ↵
    1. Tricco AC,
    2. Lillie E,
    3. Zarin W,
    4. et al
    . PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 2018;169:467–73.
    OpenUrlCrossRefPubMed
    1. Allen JG,
    2. Denny NM,
    3. Oakman N
    . Postoperative analgesia following total knee arthroplasty: a study comparing spinal anesthesia and combined sciatic femoral 3-in-1 block. Reg Anesth Pain Med 1998;23: 142–6.
    OpenUrlAbstract/FREE Full Text
    1. Andersen KV,
    2. Bak M,
    3. Christensen BV,
    4. et al
    . A randomized, controlled trial comparing local infiltration analgesia with epidural infusion for total knee arthroplasty. Acta Orthop 2010;8:606–10.
    OpenUrl
    1. Badner NH,
    2. Bourne RB,
    3. Rorabeck CH,
    4. et al
    . Intra-articular injection of bupivacaine in knee-replacement operations. Results of use for analgesia and for preemptive blockade. J Bone Joint Surg Am 1996;78:734–8.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Borckardt JJ,
    2. Reeves ST,
    3. Robinson SM,
    4. et al
    . Transcranial direct current stimulation (tDCS) reduces postsurgical opioid consumption in total knee arthroplasty (TKA). Clin J Pain 2013;29:925–8.
    OpenUrl
    1. Buvanendran A,
    2. Kroin JS,
    3. Tuman KJ,
    4. et al
    . Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. JAMA 2003;290:2411–8.
    OpenUrlCrossRefPubMed
    1. Chan IA,
    2. Maslany JG,
    3. Gorman KJ,
    4. et al
    . Dexmedetomidine during total knee arthroplasty performed under spinal anesthesia decreases opioid use: a randomized-controlled trial. Can J Anaesth 2016;63: 569–76.
    OpenUrlPubMed
    1. Essving P,
    2. Axelsson K,
    3. Kjellberg J,
    4. et al
    . Reduced morphine consumption and pain intensity with local infiltration analgesia (LIA) following total knee arthroplasty. Acta Orthop 2010;81:354–60.
    OpenUrlCrossRefPubMed
    1. Essving P,
    2. Axelsson K,
    3. Åberg E,
    4. et al
    . Local infiltration analgesia versus intrathecal morphine for postoperative pain management after total knee arthroplasty: a randomized controlled trial. Anesth Analg 2011;113:926–33.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Goyal N,
    2. McKenzie J,
    3. Sharkey PF,
    4. et al
    . The 2012 Chitranjan Ranawat award: Intraarticular analgesia after TKA reduces pain: a randomized, double-blinded, placebo-controlled, prospective study. Clin Orthop Relat Res 2013;471:64–75.
    OpenUrlCrossRefPubMed
    1. Gómez-Cardero P,
    2. Rodríguez-Merchán EC
    . Postoperative analgesia in TKA: ropivacaine continuous intraarticular infusion. Clin Orthop Relat Res 2010;468:1242–7.31.
    OpenUrlCrossRefPubMed
    1. Hanson NA,
    2. Allen CJ,
    3. Hostetter LS,
    4. et al
    . Continuous ultrasound-guided adductor canal block for total knee arthroplasty: a randomized, double-blind trial. Anesth Analg 2014;118:1370–7.
    OpenUrlCrossRefPubMed
  23. ↵
    1. He BJ,
    2. Tong PJ,
    3. Li J,
    4. et al
    . Auricular acupressure for analgesia in perioperative period of total knee arthroplasty. Pain Med 2013;14: 1608–13.
    OpenUrl
  24. ↵
    1. Ho KY,
    2. Tay W,
    3. Yeo MC,
    4. et al
    . Duloxetine reduces morphine requirements after knee replacement surgery. Br J Anaesth 2010;105:371–6.
    OpenUrlCrossRefPubMed
    1. Huang YM,
    2. Wang CM,
    3. Wang CT,
    4. et al
    . Perioperative celecoxib administration for pain management after total knee arthroplasty — a randomized, controlled study. BMC Musculoskelet Disord 2008;9:77.
    OpenUrlCrossRefPubMed
    1. Hubbard RC,
    2. Naumann TM,
    3. Traylor L,
    4. et al
    . Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia. Br J Anaesth 2003;90:166–72.
    OpenUrlCrossRefPubMed
    1. Inan N,
    2. Ozcan N,
    3. Takmaz SA,
    4. et al
    . Efficacy of lornoxicam in postoperative analgesia after total knee replacement surgery. Agri 2007; 19:38–45.
    OpenUrlPubMed
    1. Jenstrup MT,
    2. Jæger P,
    3. Lund J,
    4. et al
    . Effects of adductor-canal-blockade on pain and ambulation after total knee arthroplasty: a randomized study. Acta Anaesthesiol Scand 2012;56:357–64.
    OpenUrlCrossRefPubMed
    1. Kampitak W,
    2. Tanavalee A,
    3. Ngarmukos S,
    4. et al
    . Opioid-sparing analgesia and enhanced recovery after total knee arthroplasty using combined triple nerve blocks with local infiltration analgesia. J Arthroplasty 2019;34:295–302.
    OpenUrlPubMed
    1. Lamplot JD,
    2. Wagner ER,
    3. Manning DW
    . Multimodal pain management in total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty 2014;29:329–34.
    OpenUrlCrossRefPubMed
    1. Leung P,
    2. Dickerson DM,
    3. Denduluri SK,
    4. et al
    . Postoperative continuous adductor canal block for total knee arthroplasty improves pain and functional recovery: a randomized controlled clinical trial. J Clin Anesth 2018;49:46–52.
    OpenUrlPubMed
    1. Mont MA,
    2. Beaver WB,
    3. Dysart SH,
    4. et al
    . Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial. J Arthroplasty 2018;3:90–6.
    OpenUrl
    1. Nader A,
    2. Kendall MC,
    3. Manning DW,
    4. et al
    . Single-dose adductor canal block with local infiltrative analgesia compared with local infiltrate analgesia after total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. Reg Anesth Pain Med 2016;41:678–84.
    OpenUrlAbstract/FREE Full Text
    1. Pham Dang C,
    2. Gautheron E,
    3. Guilley J,
    4. et al
    . The value of adding sciatic block to continuous femoral block for analgesia after total knee replacement. Reg Anesth Pain Med 2005;30:128–33.
    OpenUrlAbstract/FREE Full Text
    1. Runge C,
    2. Børglum J,
    3. Jensen JM,
    4. et al
    . The analgesic effect of obturator nerve block added to a femoral triangle block after total knee arthroplasty: a randomized controlled trial. Reg Anesth Pain Med 2016;4:445–51.
    OpenUrl
    1. Sahin L,
    2. Korkmaz HF,
    3. Sahin M,
    4. et al
    . Ultrasound-guided single-injection femoral nerve block provides effective analgesia after total knee arthroplasty up to 48 hours. Agri 2014;26:113–8.
    OpenUrlPubMed
    1. Samona J,
    2. Cook C,
    3. Krupa K,
    4. et al
    . Effect of intraoperative dexamethasone on pain scores and narcotic consumption in patients undergoing total knee arthroplasty. Orthop Surg 2017;9:110–4.
    OpenUrl
    1. Sarridou DG,
    2. Chalmouki G,
    3. Braoudaki M,
    4. et al
    . Intravenous parecoxib and continuous femoral block for postoperative analgesia after total knee arthroplasty. A randomized, double-blind, prospective trial. Pain Physician 2015;18:267–76.
    OpenUrl
  25. ↵
    1. Thijs E,
    2. Schotanus MGM,
    3. Bemelmans YFL,
    4. et al
    . Reduced opiate use after total knee arthroplasty using computer-assisted cryotherapy. Knee Surg Sports Traumatol Arthrosc 2019;27:1204–12.
    OpenUrl
  26. ↵
    1. Usichenko TI,
    2. Edinger H,
    3. Witstruck T,
    4. et al
    . Millimetre wave therapy for pain relief after total knee arthroplasty: a randomised controlled trial. Eur J Pain 2008;12:617–23.
    OpenUrlPubMed
    1. Vendittoli PA,
    2. Makinen P,
    3. Drolet P,
    4. et al
    . A multimodal analgesia protocol for total knee arthroplasty. A randomized, controlled study. J Bone Joint Surg Am 2006;88:282–9.
    OpenUrlAbstract/FREE Full Text
    1. Williams D,
    2. Petruccelli D,
    3. Paul J,
    4. et al
    . Continuous infusion of bupivacaine following total knee arthroplasty: a randomized control trial pilot study. J Arthroplasty 2013;28:479–84.
    OpenUrl
    1. Banerjee P
    . The efficacy of multimodal high-volume wound infiltration in primary total knee replacement in facilitating immediate post-operative pain relief and attainment of early rehabilitation milestones. Eur J Orthop Surg Traumatol 2014;24:571–7.
    OpenUrl
    1. Chin KK,
    2. Carroll I,
    3. Desai K,
    4. et al
    . Integrating adjuvant analgesics into perioperative pain practice: results from an academic medical center. Pain Med 2020;21:161–70.
    OpenUrl
    1. Klement MR,
    2. Bullock WM,
    3. Nickel BT,
    4. et al
    . Continuous adductor canal blockade facilitates increased home discharge and decreased opioid consumption after total knee arthroplasty. Knee 2019;26:679–86.
    OpenUrlPubMed
    1. Kuo AC,
    2. Grotkopp E
    . A simple method associated with reduced opioid consumption after total knee arthroplasty. J Arthroplasty 2017;32:3034–7.
    OpenUrl
    1. Xiao X,
    2. Zhang Q,
    3. Ouyang Z,
    4. et al
    . Comparison of perioperative flurbiprofen axetil or celecoxib administration for pain management after total-knee arthroplasty: a retrospective study. Medicine (Baltimore) 2018;97:e12391.
    OpenUrl
    1. Horlocker TT,
    2. Hebl JR,
    3. Kinney MA,
    4. et al
    . Opioid-free analgesia following total knee arthroplasty — a multimodal approach using continuous lumbar plexus (psoas compartment) block, acetaminophen, and ketorolac. Reg Anesth Pain Med 2002;27:105–8.
    OpenUrlAbstract/FREE Full Text
    1. Stevenson DD,
    2. Gasko JL
    . A tale of two knee implants in the same person: narcotics for the first and anti-inflammatory drugs for the second. Clin Med Insights Case Rep 2018;11:1179547618794650.
    OpenUrl
  27. ↵
    1. Aguirre J,
    2. Baulig B,
    3. Dora C,
    4. et al
    . Continuous epicapsular ropivacaine 0.3% infusion after minimally invasive hip arthroplasty: a prospective, randomized, double-blinded, placebo-controlled study comparing continuous wound infusion with morphine patient-controlled analgesia. Anesth Analg 2012;114:456–61.
    OpenUrlCrossRefPubMed
    1. Becchi C,
    2. Al Malyan M,
    3. Coppini R,
    4. et al
    . Opioid-free analgesia by continuous psoas compartment block after total hip arthroplasty. A randomized study. Eur J Anaesthesiol 2008;25:418–23.
    OpenUrlCrossRefPubMed
    1. Bilir A,
    2. Gulec S,
    3. Erkan A,
    4. et al
    . Epidural magnesium reduces postoperative analgesic requirement. Br J Anaesth 2007;98:519–23.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Camu F,
    2. Beecher T,
    3. Recker DP,
    4. et al
    . Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty. Am J Ther 2002;9:43–51.
    OpenUrlCrossRefPubMed
    1. Clarke H,
    2. Pereira S,
    3. Kennedy D,
    4. et al
    . Adding gabapentin to a multimodal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty. Acta Anaesthesiol Scand 2009; 53:1073–83.
    OpenUrlCrossRefPubMed
    1. Desmet M,
    2. Vermeylen K,
    3. Van Herreweghe I,
    4. et al
    . A longitudinal supra-inguinal fascia iliaca compartment block reduces morphine consumption after total hip arthroplasty. Reg Anesth Pain Med 2017; 42:327–33.
    OpenUrlAbstract/FREE Full Text
    1. Fogarty DJ,
    2. O’Hanlon JJ,
    3. Milligan KR
    . Intramuscular ketorolac following total hip replacement with spinal anaesthesia and intrathecal morphine. Acta Anaesthesiol Scand 1995;39:191–4.
    OpenUrlPubMed
    1. Hwang JY,
    2. Na HS,
    3. Jeon YT,
    4. et al
    . I.V. infusion of magnesium sulphate during spinal anaesthesia improves postoperative analgesia. Br J Anaesth 2010;104:89–93.
    OpenUrlCrossRefPubMed
    1. Köroğlu S,
    2. Takmaz SA,
    3. Kaymak C,
    4. et al
    . The preoperative analgesic effect of 3-in-1 block on postoperative pain and tramadol consumption in total hip arthroplasty. Agri 2008;20:19–25.
    OpenUrlPubMed
    1. Laitinen J,
    2. Nuutinen L
    . Intravenous diclofenac coupled with PCA fentanyl for pain relief after total hip replacement. Anesthesiology 1992;76:194–8.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Lan F,
    2. Ma YH,
    3. Xue JX,
    4. et al
    . Transcutaneous electrical nerve stimulation on acupoints reduces fentanyl requirement for postoperative pain relief after total hip arthroplasty in elderly patients. Minerva Anestesiol 2012;78:887–95.
    OpenUrlPubMed
    1. Malan TP Jr.,
    2. Marsh G,
    3. Hakki SI,
    4. et al
    . Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology 2003;98:950–6.
    OpenUrlCrossRefPubMed
    1. Martinez V,
    2. Cymerman A,
    3. Ben Ammar S,
    4. et al
    . The analgesic efficiency of combined pregabalin and ketamine for total hip arthroplasty: a randomised, double-blind, controlled study. Anaesthesia 2014;69:46–52.
    OpenUrlCrossRefPubMed
    1. Murphy TP,
    2. Byrne DP,
    3. Curtin P,
    4. et al
    . Can a periarticular levobupivacaine injection reduce postoperative opiate consumption during primary hip arthroplasty? Clin Orthop Relat Res 2012;470:1151–7.
    OpenUrlCrossRefPubMed
    1. Remérand F,
    2. Le Tendre C,
    3. Baud A,
    4. et al
    . The early and delayed analgesic effects of ketamine after total hip arthroplasty: a prospective, randomized, controlled, double-blind study. Anesth Analg 2009; 109:1963–71.
    OpenUrlCrossRefPubMed
    1. Serpell MG,
    2. Thomson MF
    . Comparison of piroxicam with placebo in the management of pain after total hip replacement. Br J Anaesth 1989;63:354–6.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Siddiqui ZI,
    2. Cepeda MS,
    3. Denman W,
    4. et al
    . Continuous lumbar plexus block provides improved analgesia with fewer side effects compared with systemic opioids after hip arthroplasty: a randomized controlled trial. Reg Anesth Pain Med 2007;32:393–8.
    OpenUrlAbstract/FREE Full Text
    1. Stevens M,
    2. Harrison G,
    3. McGrail M
    . A modified fascia iliaca compartment block has significant morphine-sparing effect after total hip arthroplasty. Anaesth Intensive Care 2007;35:949–52.
    OpenUrlPubMed
  31. ↵
    1. Ward JP,
    2. Albert DB,
    3. Altman R,
    4. et al
    . Are femoral nerve blocks effective for early postoperative pain management after hip arthroscopy? Arthroscopy 2012;28:1064–9.
    OpenUrlCrossRefPubMed
    1. Gürkan Y,
    2. Yörükoğlu HU,
    3. Işık E,
    4. et al
    . The effect of ibuprofen on postoperative opioid consumption following total hip replacement surgery. Turk J Anaesthesiol Reanim 2019;47:31–4.
    OpenUrl
    1. Post ZD,
    2. Restrepo C,
    3. Kahl LK,
    4. et al
    . A prospective evaluation of 2 different pain management protocols for total hip arthroplasty. J Arthroplasty 2010;25:410–5.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Banerjee P,
    2. McLean C
    . The efficacy of multimodal high-volume wound infiltration in primary total hip replacement. Orthopedics 2011;34:e522–29.
    OpenUrlPubMed
    1. Maheshwari AV,
    2. Boutary M,
    3. Yun AG,
    4. et al
    . Multimodal analgesia without routine parenteral narcotics for total hip arthroplasty. Clin Orthop Relat Res 2006;453:231–8.
    OpenUrlCrossRefPubMed
    1. Uusalo P,
    2. Jätinvuori H,
    3. Löyttyniemi E,
    4. et al
    . Intranasal low-dose dexmedetomidine reduces postoperative opioid requirement in patients undergoing hip arthroplasty under general anesthesia. J Arthroplasty 2019;34:686–92.e2.
    OpenUrl
  33. ↵
    1. VanWagner MJ,
    2. Krebs NM,
    3. Corser W,
    4. et al
    . Liposomal bupivacaine reduces opioid consumption and length of stay in patients undergoing primary total hip arthroplasty. Hip Int 2019;29:276–81.
    OpenUrl
  34. ↵
    1. Alexander R,
    2. El-Moalem HE,
    3. Gan TJ
    . Comparison of the morphine-sparing effects of diclofenac sodium and ketorolac tromethamine after major orthopedic surgery. J Clin Anesth 2002;14: 187–92.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Arcioni R,
    2. Palmisani S,
    3. Tigano S,
    4. et al
    . Combined intrathecal and epidural magnesium sulfate supplementation of spinal anesthesia to reduce post-operative analgesic requirements: a prospective, randomized, double-blind, controlled trial in patients undergoing major orthopedic surgery. Acta Anaesthesiol Scand 2007;51:482–9.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Boeckstyns MEH,
    2. Backer M,
    3. Petersen EM,
    4. et al
    . Piroxicam spares buprenorphine after total joint replacement: controlled study of pain treatment in 81 patients. Acta Orthop Scand 1992;63:658–60.
    OpenUrlPubMed
  37. ↵
    1. Oberhofer D,
    2. Šakić K,
    3. Nesek-Adam V,
    4. et al
    . Low dose spinal morphine and intravenous diclofenac for postoperative analgesia after total hip and knee arthroplasty. Period Biol 2011;113:191–6.
    OpenUrl
  38. ↵
    1. Kazerooni R,
    2. Bounthavong M,
    3. Tran JN,
    4. et al
    . Retrospective evaluation of inpatient celecoxib use after total hip and knee arthroplasty at a Veterans Affairs medical center. J Arthroplasty 2012;27:1033–40.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Singla N,
    2. Rock A,
    3. Pavliv L
    . A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients. Pain Med 2010;11:1284–93.
    OpenUrl
  40. ↵
    1. Raiff D,
    2. Vaughan C,
    3. Mcgee A
    . Impact of intraoperative acetaminophen administration on postoperative opioid consumption in patients undergoing hip or knee replacement. Hosp Pharm 2014;49: 1022–32.
    OpenUrl
    1. Aveline C,
    2. Hetet HL,
    3. Vautier P,
    4. et al
    . Peroperative ketamine and morphine for postoperative pain control after lumbar disk surgery. Eur J Pain 2006;10:653–8.
    OpenUrlCrossRefPubMed
    1. Cassinelli EH,
    2. Dean CL,
    3. Garcia RM,
    4. et al
    . Ketorolac use for postoperative pain management following lumbar decompression surgery: a prospective, randomized, double-blinded, placebo-controlled trial. Spine (Phila Pa 1976) 2008;33:1313–7.
    OpenUrl
  41. ↵
    1. Farag E,
    2. Ghobrial M,
    3. Sessler D,
    4. et al
    . Effect of perioperative intravenous lidocaine administration on pain, opioid consumption, and quality of life after complex spine surgery. Anesthesiology 2013;119: 932–40.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Fujita N,
    2. Tobe M,
    3. Tsukamoto N,
    4. et al
    . A randomized placebo-controlled study of preoperative pregabalin for postoperative analgesia in patients with spinal surgery. J Clin Anesth 2016;31:149–53.
    OpenUrl
  43. ↵
    1. Garcia RM,
    2. Cassinelli EH,
    3. Messerschmitt PJ,
    4. et al
    . A multimodal approach for postoperative pain management after lumbar decompression surgery: a prospective, randomized study. J Spinal Disord Tech 2013;26:291–7.
    OpenUrlCrossRefPubMed
    1. Garg N,
    2. Panda NB,
    3. Gandhi KA,
    4. et al
    . Comparison of small dose ketamine and dexmedetomidine infusion for postoperative analgesia in spine surgery — a prospective randomized double-blind placebo controlled study. J Neurosurg Anesthesiol 2016;28:27–31.
    OpenUrl
  44. ↵
    1. Glaser J,
    2. Reeves ST,
    3. Stoll WD,
    4. et al
    . Motor/prefrontal transcranial direct current stimulation (tDCS) following lumbar surgery reduces postoperative analgesia use. Spine 2016;41:835–9.
    OpenUrl
  45. ↵
    1. Gottschalk A,
    2. Freitag M,
    3. Tank S,
    4. et al
    . Quality of postoperative pain using an intraoperatively placed epidural catheter after major lumbar spinal surgery. Anesthesiology 2004;101:175–80.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Hernández-Palazón J,
    2. Tortosa JA,
    3. Martínez-Lage JF,
    4. et al
    . Intravenous administration of propacetamol reduces morphine consumption after spinal fusion surgery. Anesth Analg 2001;92:1473–6.
    OpenUrlCrossRefPubMed
    1. Jirarattanaphochai K,
    2. Jung S,
    3. Thienthong S,
    4. et al
    . Peridural methylprednisolone and wound infiltration with bupivacaine for postoperative pain control after posterior lumbar spine surgery: a randomized double-blinded placebo-controlled trial. Spine (Phila Pa 1976) 2007; 32:609–16, discussion 617.
    OpenUrl
    1. Karst M,
    2. Kegel T,
    3. Lukas A,
    4. et al
    . Effect of celecoxib and dexamethasone on postoperative pain after lumbar disc surgery. Neurosurgery 2003;53:331–6, discussion 336–7.
    OpenUrlCrossRefPubMed
    1. Kesimci E,
    2. Gümüş T,
    3. Izdeş S,
    4. et al
    . Comparison of efficacy of dexketoprofen versus paracetamol on postoperative pain and morphine consumption in laminectomy patients. Agri 2011;23:153–9.
    OpenUrlPubMed
  47. ↵
    1. Kim SH,
    2. Kim SI,
    3. Ok SY,
    4. et al
    . Opioid sparing effect of low dose ketamine in patients with intravenous patient-controlled analgesia using fentanyl after lumbar spinal fusion surgery. Korean J Anesthesiol 2013;64:524–8.
    OpenUrlCrossRefPubMed
    1. Naik BI,
    2. Nemergut EC,
    3. Kazemi A,
    4. et al
    . The effect of dexmedetomidine on postoperative opioid consumption and pain after major spine surgery. Anesth Analg 2016;122:1646–53.
    OpenUrl
  48. ↵
    1. Pandey CK,
    2. Sahay S,
    3. Gupta D,
    4. et al
    . Preemptive gabapentin decreases postoperative pain after lumbar discoidectomy. Can J Anaesth 2004;51:986–9.
    OpenUrlPubMed
    1. Rajpal S,
    2. Gordon DB,
    3. Pellino TA,
    4. et al
    . Comparison of perioperative oral multimodal analgesia versus IV PCA for spine surgery. J Spinal Disord Tech 2010;23:139–45.
    OpenUrlCrossRefPubMed
    1. Riest G,
    2. Peters J,
    3. Weiss M,
    4. et al
    . Does perioperative administration of rofecoxib improve analgesia after spine, breast and orthopaedic surgery? Eur J Anaesthesiol 2006;23:219–26.
    OpenUrlCrossRefPubMed
    1. Rowe WL,
    2. Goodwin AP,
    3. Miller AJ
    . The efficacy of pre-operative controlled-release indomethacin in the treatment of post-operative pain. Curr Med Res Opin 1992;12:662–7.
    OpenUrlPubMed
    1. Singh S,
    2. Choudhary NK,
    3. Lalin D,
    4. et al
    . Bilateral ultrasound-guided erector spinae plane block for postoperative analgesia in lumbar spine surgery: a randomized control trial. J Neurosurg Anesthesiol 2020;32:330–4.
    OpenUrlPubMed
  49. ↵
    1. Turan A,
    2. Karamanlioğlu B,
    3. Memiş D,
    4. et al
    . Analgesic effects of gabapentin after spinal surgery. Anesthesiology 2004;100:935–8.
    OpenUrlCrossRefPubMed
    1. Unterrainer AF,
    2. Al-Schameri AR,
    3. Piotrowski WP,
    4. et al
    . Opioid sparing effect of epidural levobupivacaine on postoperative pain treatment in major spinal surgery. Middle East J Anaesthesiol 2008;19: 781–8.
    OpenUrlPubMed
  50. ↵
    1. Unterrainer AF,
    2. Freidrich C,
    3. Krenn M,
    4. et al
    . Postoperative and preincisional electrical nerve stimulation TENS reduce postoperative opioid requirement after major spinal surgery. J Neurosurg Anesthesiol 2010;22:1–5.
    OpenUrlPubMed
    1. Yamashita K,
    2. Fukusaki M,
    3. Ando Y,
    4. et al
    . Preoperative administration of intravenous flurbiprofen axetil reduces postoperative pain for spinal fusion surgery. J Anesth 2006;20:92–5.
    OpenUrlPubMed
  51. ↵
    1. Ali ZS,
    2. Flanders TM,
    3. Ozturk AK,
    4. et al
    . Enhanced recovery after elective spinal and peripheral nerve surgery: pilot study from a single institution. J Neurosurg Spine 2019;30:1–9.
    OpenUrlCrossRef
  52. ↵
    1. Lovecchio F,
    2. Stepan JG,
    3. Premkumar A,
    4. et al
    . An institutional intervention to modify opioid prescribing practices after lumbar spine surgery. J Neurosurg Spine 2019;5:1–8.
    OpenUrl
  53. ↵
    1. Bohl DD,
    2. Louie PK,
    3. Shah N,
    4. et al
    . Multimodal versus patient-controlled analgesia after an anterior cervical decompression and fusion. Spine 2016;41:994–8.
    OpenUrlCrossRefPubMed
  54. ↵
    1. Smith AN,
    2. Hoefling VC
    . A retrospective analysis of intravenous acetaminophen use in spinal surgery patients. Pharm Pract (Granada) 2014;12:417.
    OpenUrl
    1. Soffin EM,
    2. Wetmore DS,
    3. Beckman JD,
    4. et al
    . Opioid-free anesthesia within an Enhanced Recovery After Surgery pathway for minimally invasive lumbar spine surgery: a retrospective matched cohort study. Neurosurg Focus 2019;46:E8.
    OpenUrlCrossRefPubMed
    1. Chin KJ,
    2. Lewis S
    . Opioid-free analgesia for posterior spinal fusion surgery using erector spinae plane (ESP) blocks in a multimodal anesthetic regimen. Spine (Phila Pa 1976) 2019;44: E379–83.
    OpenUrl
  55. ↵
    1. Ahn S,
    2. Byun SH,
    3. Park K,
    4. et al
    . Analgesic efficacy of preemptive pregabalin administration in arthroscopic shoulder surgery: a randomized controlled trial. Can J Anesth 2016;63:283–9.
    OpenUrl
  56. ↵
    1. Butterfield NN,
    2. Schwarz SKW,
    3. Ries CR,
    4. et al
    . Combined pre- and post-surgical bupivacaine wound infiltrations decrease opioid requirements after knee ligament reconstruction Can J Anaesth 2001; 48:245–50.
    OpenUrlCrossRefPubMed
    1. Ekman EF,
    2. Wahba M,
    3. Ancona F
    . Analgesic efficacy of perioperative celecoxib in ambulatory arthroscopic knee surgery: a double-blind, placebo-controlled study. Arthroscopy 2006;22:635–42.
    OpenUrlCrossRefPubMed
    1. Hoenecke HR Jr.,
    2. Pulido PA,
    3. Morris BA,
    4. et al
    . The efficacy of continuous bupivacaine infiltration following anterior cruciate ligament reconstruction. Arthroscopy 2002;18:854–8.
    OpenUrlCrossRefPubMed
    1. Ilan DI,
    2. Liporace FA,
    3. Rosen J,
    4. et al
    . Efficacy of rofecoxib for pain control after knee arthroscopy: a prospective, randomized, double-blinded clinical trial. Arthroscopy 2004;20:813–8.
    OpenUrlPubMed
  57. ↵
    1. Lierz P,
    2. Losch H,
    3. Felleiter P
    . Evaluation of a single preoperative dose of etoricoxib for postoperative pain relief in therapeutic knee arthroscopy: a randomized trial. Acta Orthop 2012; 83:642–7.
    OpenUrlPubMed
  58. ↵
    1. Mahure SA,
    2. Rokito AS,
    3. Kwon YW
    . Transcutaneous electrical nerve stimulation for postoperative pain relief after arthroscopic rotator cuff repair: a prospective double-blinded randomized trial. J Shoulder Elbow Surg 2017;26:1508–13.
    OpenUrl
    1. Mardani-Kivi M,
    2. Karimi Mobarakeh M,
    3. Haghighi M,
    4. et al
    . Celecoxib as a pre-emptive analgesia after arthroscopic knee surgery; a triple-blinded randomized controlled trial. Arch Orthop Trauma Surg 2013;133:1561–6.
    OpenUrlCrossRefPubMed
  59. ↵
    1. Mardani-Kivi M,
    2. Karimi Mobarakeh M,
    3. Keyhani S,
    4. et al
    . Arthroscopic Bankart surgery: Does gabapentin reduce postoperative pain and opioid consumption? A triple-blinded randomized clinical trial. Orthop Traumatol Surg Res 2016;102:549–53.
    OpenUrl
  60. ↵
    1. Montazeri K,
    2. Kashefi P,
    3. Honarmand A
    . Pre-emptive gabapentin significantly reduces postoperative pain and morphine demand following lower extremity orthopaedic surgery. Singapore Med J 2007; 48:748–51.
    OpenUrlPubMed
    1. Ringrose NH,
    2. Cross MJ
    . Femoral nerve block in knee joint surgery. Am J Sports Med 1984;12:398–402.
    OpenUrlCrossRefPubMed
    1. Saritas TB,
    2. Borazan H,
    3. Okesli S,
    4. et al
    . Is intra-articular magnesium effective for postoperative analgesia in arthroscopic shoulder surgery? Pain Res Manag 2015;20:35–8.
    OpenUrl
  61. ↵
    1. Syed UAM,
    2. Aleem AW,
    3. Wowkanech C,
    4. et al
    . Neer Award 2018: The effect of preoperative education on opioid consumption in patients undergoing arthroscopic rotator cuff repair: a prospective, randomized clinical trial. J Shoulder Elbow Surg 2018;27:962–7.
    OpenUrl
    1. Matheny JM,
    2. Hanks GA,
    3. Rung GW,
    4. et al
    . A comparison of patient-controlled analgesia and continuous lumbar plexus block after anterior cruciate ligament reconstruction. Arthroscopy 1993;9:87–90.
    OpenUrlPubMed
    1. Edkin BS,
    2. Spindler KP,
    3. Flanagan JF
    . Femoral nerve block as an alternative to parenteral narcotics for pain control after anterior cruciate ligament reconstruction. Arthroscopy 1995;11:404–9.
    OpenUrlPubMed
    1. Argoff C,
    2. McCarberg B,
    3. Gudin J,
    4. et al
    . SoluMatrix® diclofenac: sustained opioid-sparing effects in a phase 3 study in patients with postoperative pain. Pain Med 2016;17:1933–41.
    OpenUrl
    1. Bech RD,
    2. Lauritsen J,
    3. Ovesen O,
    4. et al
    . Local anaesthetic wound infiltration after internal fixation of femoral neck fractures: a randomized, double-blind clinical trial in 33 patients. Hip Int 2011;21: 251–9.
    OpenUrlPubMed
  62. ↵
    1. Delbos A,
    2. Boccard E
    . The morphine-sparing effect of propacetamol in orthopedic postoperative pain. J Pain Symptom Manage 1995;10: 279–86.
    OpenUrlCrossRefPubMed
    1. Diaz-Borjon E,
    2. Torres-Gomez A,
    3. et al
    . Parecoxib provides analgesic and opioid-sparing effects following major orthopedic surgery: a subset analysis of a randomized, placebo-controlled clinical trial. Pain Ther 2017;6:61–72.
    OpenUrl
    1. El-Kerdawy H
    . Analgesic requirements for patients undergoing lower extremity orthopedic surger — the effect of combined spinal and epidural magnesium. Middle East J Anaesthesiol 2008;19: 1013–25.
    OpenUrlPubMed
    1. Fredman B,
    2. Zohar E,
    3. Tarabykin A,
    4. et al
    . Continuous intravenous diclofenac does not induce opioid-sparing or improve analgesia in geriatric patients undergoing major orthopedic surgery. J Clin Anesth 2000;12:531–6.
    OpenUrlPubMed
    1. Gehling MH,
    2. Luesebrink T,
    3. Kulka PJ,
    4. et al
    . The effective duration of analgesia after intrathecal morphine in patients without additional opioid analgesia: a randomized double-blind multicentre study on orthopaedic patients. Eur J Anaesthesiol 2009;26:683–8.
    OpenUrlCrossRefPubMed
    1. Hamal PK,
    2. Shrestha AB,
    3. Shrestha RR
    . Efficacy of preemptive gabapentin for lower extremity orthopedic surgery under subarachnoid block. JNMA J Nepal Med Assoc 2015;53:210–3.
    OpenUrl
    1. Jones SF,
    2. White A
    . Analgesia following femoral neck surgery. Lateral cutaneous nerve block as an alternative to narcotics in the elderly. Anaesthesia 1985;40:682–5.
    OpenUrlPubMed
    1. Kinsella J,
    2. Moffat AC,
    3. Patrick JA,
    4. et al
    . Ketorolac trometamol for postoperative analgesia after orthopaedic surgery. Br J Anaesth 1992; 69:19–22.
    OpenUrlCrossRefPubMed
    1. Mattila K,
    2. Kontinen VK,
    3. Kalso E,
    4. et al
    . Dexamethasone decreases oxycodone consumption following osteotomy of the first metatarsal bone: a randomized controlled trial in day surgery. Acta Anaesthesiol Scand 2010;54:268–76.
    OpenUrlCrossRefPubMed
    1. Mostafa SF,
    2. Eid GM,
    3. Elkalla RS
    . Patient-controlled fascia iliaca compartment block versus fentanyl patient-controlled intravenous analgesia in patients undergoing femur fracture surgery. Egyptian J Anesth 2018;34:9–13.
    OpenUrl
    1. Park J,
    2. Forrest J,
    3. Kolesar R,
    4. et al
    . Oral clonidine reduces postoperative PCA morphine requirements. Can J Anaesth 1996;43:900–6.
    OpenUrlPubMed
  63. ↵
    1. Sanzone AG
    . Use of nonopioid analgesics and the impact on patient outcomes. J Orthop Trauma 2016;30:S12–5.
    OpenUrl
    1. Southworth S,
    2. Peters J,
    3. Rock A,
    4. et al
    . A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Clin Ther 2009;31:1922–35.
    OpenUrlCrossRefPubMed
    1. Twiston-Davies CW,
    2. Goodwin MI,
    3. Baxter PJ
    . Rectal indomethacin for postoperative pain in orthopaedic surgery. A double-blind study. J Bone Joint Surg Br 1990;72:510–1.
    OpenUrl
  64. ↵
    1. Waikakul W,
    2. Chalachewa T,
    3. Tantisirin N,
    4. et al
    . Combination of gabapentin and celecoxib for analgesia after major orthopedic surgery: a randomized, controlled trial. Asian Biomedicine 2011;5:101–10.
    OpenUrl
    1. Weinbroum AA
    . Dextromethorphan reduces immediate and late postoperative analgesic requirements and improves patients’ subjective scorings after epidural lidocaine and general anesthesia. Anesth Analg 2002;94:1547–52.
    OpenUrlPubMed
    1. Xu W,
    2. Zhang N,
    3. Ni M,
    4. et al
    . The comparative study on the combination of ketorolac tromethamine and sufentanil for postoperative analgesia in patients receiving traumatic lower limb surgery: a randomized controlled trial. Int J Clin Exp Med 2016;9:2969–76.
    OpenUrl
  65. ↵
    1. Zhao JN,
    2. Kong M,
    3. Qi B,
    4. et al
    . Comparison of the morphine-sparing effect of intraoperative dexmedetomidine with and without loading dose following general anesthesia in multiple-fracture patients: a prospective, randomized, controlled clinical trial. Medicine 2016;95: e4576.
    OpenUrl
  66. ↵
    1. Dwyer CL,
    2. Soong M,
    3. Hunter A,
    4. et al
    . Prospective evaluation of an opioid reduction protocol in hand surgery. J Hand Surg Am 2018;43: 516–22.e1.
    OpenUrl
  67. ↵
    1. McLaughlin DC,
    2. Cheah JW,
    3. Aleshi P,
    4. et al
    . Multimodal analgesia decreases opioid consumption after shoulder arthroplasty: a prospective cohort study. J Shoulder Elbow Surg 2018;27:686–91.
    OpenUrlPubMed
    1. Robbins J,
    2. Green CL,
    3. Parekh SG
    . Liposomal bupivacaine in forefoot surgery. Foot Ankle Int 2015;36:503–7.
    OpenUrlCrossRefPubMed
    1. Ayling OG,
    2. Montbriand J,
    3. Jiang J,
    4. et al
    . Continuous regional anaesthesia provides effective pain management and reduces opioid requirement following major lower limb amputation. Eur J Vasc Endovasc Surg 2014;48:559–64.
    OpenUrlCrossRefPubMed
  68. ↵
    1. Cao X,
    2. Yumul R,
    3. Loani O,
    4. et al
    . Effect of intraoperative or postoperative intravenous acetaminophen on postoperative pain scores and opioid requirements in abdominal and spinal surgery patients. Int J Clin Exp Med 2018;11:4120–5.
    OpenUrl
  69. ↵
    1. Stepan JG,
    2. Sacks HA,
    3. Lovecchio FC,
    4. et al
    . Opioid prescriber education and guidelines for ambulatory upper-extremity surgery: evaluation of an institutional protocol. J Hand Surg Am 2019;44:129–36.
    OpenUrl
    1. Maurer K,
    2. Ekatodramis G,
    3. Rentsch K,
    4. et al
    . Interscalene and infraclavicular block for bilateral distal radius fracture. Anesth Analg 2002; 94:450–2.
    OpenUrlPubMed
  70. ↵
    1. Verret M,
    2. Lauzier F,
    3. Zarychanski R,
    4. et al
    . Perioperative use of gabapentinoids for the management of postoperative acute pain: a systematic review and meta-analysis. Anesthesiology 2020;133:265–79.
    OpenUrlCrossRefPubMed
  71. ↵
    1. Kehlet H
    . Postoperative opioid sparing to hasten recovery: What are the issues? Anesthesiology 2005;102:1083–5.
    OpenUrlCrossRefPubMed
    1. Ladha KS,
    2. Patorno E,
    3. Huybrechts KF,
    4. et al
    . Variations in the use of perioperative multimodal analgesic therapy. Anesthesiology 2016;124: 837–45.
    OpenUrlCrossRefPubMed
    1. Rawal N
    . Current issues in postoperative pain management. Eur J Anaesthesiol 2016;33:160–71.
    OpenUrlPubMed
  72. ↵
    1. Lirk P,
    2. Rathmell J
    . Opioid-free anaesthesia: Con: it is too early to adopt opioid-free anaesthesia today. Eur J Anaesthesiol 2019;36: 250–4.
    OpenUrl
  73. ↵
    1. Althaus A,
    2. Arránz Becker O,
    3. Moser KH,
    4. et al
    . Postoperative pain trajectories and pain chronification — an empirical typology of pain patients. Pain Med 2018;19:2536–45.
    OpenUrl
    1. Hah JM,
    2. Cramer E,
    3. Hilmoe H,
    4. et al
    . Factors associated with acute pain estimation, postoperative pain resolution, opioid cessation, and recovery: secondary analysis of a randomized clinical trial. JAMA Netw Open 2019;2:e190168.
    OpenUrl
    1. Houle TT,
    2. Miller S,
    3. Lang JE,
    4. et al
    . Day-to-day experience in resolution of pain after surgery. Pain 2017;158:2147–54.
    OpenUrl
  74. ↵
    1. Pagé MG,
    2. Kudrina I,
    3. Zomahoun HTV,
    4. et al
    . A systematic review of the relative frequency and risk factors for prolonged opioid prescription following surgery and trauma among adults. Ann Surg 2020; 271:845–54.
    OpenUrl
  75. ↵
    1. Meissner W,
    2. Zaslansky R
    . A survey of postoperative pain treatments and unmet needs. Best Pract Res Clin Anaesthesiol 2019;33:269–86.
    OpenUrlPubMed
  76. ↵
    1. Waljee JF,
    2. Zhong L,
    3. Hou H,
    4. et al
    . The use of opioid analgesics following common upper extremity surgical procedures: a national, population-based study. Plast Reconstr Surg 2016;137: 355e–64e.
    OpenUrlCrossRefPubMed
  77. ↵
    1. Inacio MCS,
    2. Hansen C,
    3. Pratt NL,
    4. et al
    . Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study. BMJ Open 2016;6: e010664.
    OpenUrlAbstract/FREE Full Text
  78. ↵
    1. Johnson SP,
    2. Chung KC,
    3. Zhong L,
    4. et al
    . Risk of prolonged opioid use among opioid-naïve patients following common hand surgery procedures. J Hand Surg Am 2016;41:947–57.e3.
    OpenUrlCrossRefPubMed
  79. ↵
    1. Nicholson AD,
    2. Kassam HF,
    3. Steele JL,
    4. et al
    . Development of a clinical risk calculator for prolonged opioid use after shoulder surgery. J Shoulder Elbow Surg 2019;28:2225–31.
    OpenUrl
  80. ↵
    1. Brown R,
    2. Deyo B,
    3. Riley C,
    4. et al
    . Screening in Trauma for Opioid Misuse Prevention (STOMP): study protocol for the development of an opioid risk screening tool for victims of injury. Addict Sci Clin Pract 2017;12:28.
    OpenUrl
  81. ↵
    1. Edwards DA,
    2. Hedrick TL,
    3. Jayaram J,
    4. et al
    .POQI-4 Working Group. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Management of Patients on Preoperative Opioid Therapy. Anesth Analg 2019;129:553–66.
    OpenUrlPubMed
  82. ↵
    1. Page AJ,
    2. Gani F,
    3. Crowley KT,
    4. et al
    . Patient outcomes and provider perceptions following implementation of a standardized perioperative care pathway for open liver resection. Br J Surg 2016;103: 564–71.
    OpenUrl
  83. ↵
    1. Talboys R,
    2. Mak M,
    3. Modi N,
    4. et al
    . Enhanced recovery programme reduces opiate consumption in hip hemiarthroplasty. Eur J Orthop Surg Traumatol 2016;26:177–81.
    OpenUrl
  84. ↵
    1. Ladha KS,
    2. Patorno E,
    3. Liu J,
    4. et al
    . Impact of perioperative epidural placement on postdischarge opioid use in patients undergoing abdominal surgery. Anesthesiology 2016;124:396–403.
    OpenUrl
    1. Mueller KG,
    2. Memtsoudis SG,
    3. Mariano ER,
    4. et al
    . Lack of association between the use of nerve blockade and the risk of persistent opioid use among patients undergoing shoulder arthroplasty: evidence from the Marketscan Database. Anesth Analg 2017;125: 1014–20.
    OpenUrl
  85. ↵
    1. Sun EC,
    2. Bateman BT,
    3. Memtsoudis SG,
    4. et al
    . Lack of association between the use of nerve blockade and the risk of postoperative chronic opioid use among patients undergoing total knee arthroplasty: evidence from the Marketscan Database. Anesth Analg 2017;125:999–1007.
    OpenUrlPubMed
  86. ↵
    1. Fujii MH,
    2. Hodges AC,
    3. Russell RL,
    4. et al
    . Post-discharge opioid prescribing and use after common surgical procedure. J Am Coll Surg 2018;226:1004–12.
    OpenUrlPubMed
  87. ↵
    1. Chapman CR,
    2. Stevens DA,
    3. Lipman AG
    . Quality of postoperative pain management in American versus European institutions. J Pain Palliat Care Pharmacother 2013;27:350–8.
    OpenUrl
  88. ↵
    1. Fiore JF,
    2. Olleik G,
    3. El-Kefraoui C,
    4. et al
    . Preventing opioid prescription after major surgery: a scoping review of opioid-free analgesia. Br J Anaesth 2019;123:627–36.
    OpenUrl
  89. ↵
    1. Lovecchio F,
    2. Premkumar A,
    3. Stepan JG,
    4. et al
    . Fighting back: institutional strategies to combat the opioid epidemic: a systematic review. HSS J 2019;15:66–71.
    OpenUrlCrossRef
  90. ↵
    1. Martinez V,
    2. Beloeil H,
    3. Marret E,
    4. et al
    . Non-opioid analgesics in adults after major surgery: systematic review with network meta-analysis of randomized trials. Br J Anaesth 2017;118:22–31.
    OpenUrlCrossRefPubMed
  91. ↵
    1. Gelineau AM,
    2. King MR,
    3. Ladha KS,
    4. et al
    . Intraoperative esmolol as an adjunct for perioperative opioid and postoperative pain reduction: a systematic review, meta-analysis, and meta-regression. Anesth Analg 2018;126:1035–49.
    OpenUrl
  92. ↵
    1. Gewandter JS,
    2. Smith SM,
    3. Dworkin RH,
    4. et al
    . Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendations. Pain 2021;162: 2669–81.
    OpenUrlCrossRefPubMed
  93. ↵
    1. Kissin I
    . Patient-controlled-analgesia analgesimetry and its problems. Anesth Analg 2009;108:1945–9.
    OpenUrlCrossRefPubMed
  94. ↵
    1. Dai F,
    2. Silverman DG,
    3. Chelly JE,
    4. et al
    . Integration of pain score and morphine consumption in analgesic clinical studies. J Pain 2013;14: 767–77.e8.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Journal of Surgery: 65 (5)
CAN J SURG
Vol. 65, Issue 5
25 Oct 2022
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CJS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reduction of opioid use after orthopedic surgery: a scoping review
(Your Name) has sent you a message from CJS
(Your Name) thought you would like to see the CJS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Reduction of opioid use after orthopedic surgery: a scoping review
Jessica Gormley, Kyle Gouveia, Seaher Sakha, Veronica Stewart, Ushwin Emmanuel, Michael Shehata, Daniel Tushinski, Harsha Shanthanna, Kim Madden
CAN J SURG Oct 2022, 65 (5) E695-E715; DOI: 10.1503/cjs.023620

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Reduction of opioid use after orthopedic surgery: a scoping review
Jessica Gormley, Kyle Gouveia, Seaher Sakha, Veronica Stewart, Ushwin Emmanuel, Michael Shehata, Daniel Tushinski, Harsha Shanthanna, Kim Madden
CAN J SURG Oct 2022, 65 (5) E695-E715; DOI: 10.1503/cjs.023620
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Publication Fees
  • Forms
  • Editorial Policies
  • Submit a manuscript

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

All editorial matter in CJS represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

View CMA's Accessibility policy.

Powered by HighWire